(ANVS) Annovis Bio - Performance -74.4% in 12m
ANVS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-47.68%
#66 in Peer-Group
Rel. Strength
4.13%
#7392 in Stock-Universe
Total Return 12m
-74.35%
#168 in Peer-Group
Total Return 5y
-38.02%
#49 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 15.46 USD |
| 52 Week Low | 1.22 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 60.00 |
| Buy/Sell Signal +-5 | 2.05 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ANVS (-74.4%) vs XBI (-7.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.11% | 68.3% | 77.5% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.3% | -6.89% | 148% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.9% | -1.4% | 35.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
0.57% | 33% | -5.3% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.89% | -5.88% | 1.36% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.2% | 59.2% | -5.89% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.66% | 61.7% | -9.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.23% | 38.8% | 14.5% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ANVS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ANVS
| Total Return (including Dividends) | ANVS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -9.85% | 4.38% | 4.99% |
| 3 Months | 49.69% | 5.22% | 10.23% |
| 12 Months | -74.35% | -7.16% | 14.42% |
| 5 Years | -38.02% | -24.61% | 110.17% |
| Trend Score (consistency of price movement) | ANVS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -74.2% | 3.5% | 79.1% |
| 3 Months | 87.1% | 75.7% | 95.5% |
| 12 Months | -88.6% | -85.1% | 44.7% |
| 5 Years | -44.8% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th22.00 | -13.63% | -14.13% |
| 3 Month | %th88.50 | 42.26% | 35.79% |
| 12 Month | %th16.50 | -72.38% | -77.59% |
| 5 Years | %th76.50 | -17.79% | -70.51% |
FAQs
Does Annovis Bio (ANVS) outperform the market?
No,
over the last 12 months ANVS made -74.35%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.16%.
Over the last 3 months ANVS made 49.69%, while XBI made 5.22%.
Performance Comparison ANVS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ANVS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.7% | -14.8% | -60.2% | -89% |
| US NASDAQ 100 | QQQ | 2.2% | -15.2% | -61.7% | -88% |
| German DAX 40 | DAX | 2.7% | -9.3% | -71.7% | -105% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.5% | -14% | -60.6% | -92% |
| Hongkong Hang Seng | HSI | 3.7% | -17% | -78.7% | -111% |
| India NIFTY 50 | INDA | 2.8% | -11.8% | -57.5% | -74% |
| Brasil Bovespa | EWZ | -0.9% | -17.8% | -83.1% | -88% |
ANVS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.8% | -15.6% | -64.5% | -101% |
| Consumer Discretionary | XLY | 0.7% | -12.7% | -53.3% | -93% |
| Consumer Staples | XLP | 1.5% | -9.7% | -59.6% | -84% |
| Energy | XLE | 1.1% | -16% | -55.3% | -73% |
| Financial | XLF | 1.6% | -13.4% | -63.3% | -103% |
| Health Care | XLV | 2.8% | -12.3% | -52.6% | -70% |
| Industrial | XLI | 0.9% | -14% | -67% | -98% |
| Materials | XLB | -1.4% | -15.7% | -64.4% | -81% |
| Real Estate | XLRE | 2.6% | -10.7% | -58.7% | -87% |
| Technology | XLK | 2.2% | -18.9% | -63.1% | -86% |
| Utilities | XLU | 3% | -9.4% | -61.4% | -97% |
| Aerospace & Defense | XAR | 1.5% | -17.4% | -78.5% | -123% |
| Biotech | XBI | 2.1% | -14.2% | -46.1% | -67% |
| Homebuilder | XHB | -3.2% | -21.5% | -54.1% | -81% |
| Retail | XRT | -0.9% | -15.4% | -55% | -85% |
ANVS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.8% | -18.5% | -51.7% | -68% |
| Natural Gas | UNG | 6.6% | -1.3% | -44.1% | -68% |
| Gold | GLD | 3.2% | -9.1% | -79.4% | -118% |
| Silver | SLV | 3.2% | -15.1% | -76.9% | -98% |
| Copper | CPER | -0.5% | -16% | -80.8% | -92% |
ANVS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.5% | -13.1% | -55.6% | -75% |
| iShares High Yield Corp. Bond | HYG | 3.2% | -11.8% | -58.3% | -85% |